https://pipelinereview.com/eisai-inc-announces-positive-topline-results-from-camellia-timi-61-a-large-scale-cardiovascular-outcome-trial-for-the-anti-obesity-agent-belviq/
Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®